Chemours Approves New Executive Severance Policy with Enhanced Payouts
Reuters
Nov 01, 2025
Chemours Approves New Executive Severance Policy with Enhanced Payouts
The Chemours Company has adopted a new Executive Severance Policy, effective October 28, 2025, providing specific severance terms for executive officers and certain employees. Under the policy, the Chief Executive Officer is eligible for a cash severance payment equal to twice the sum of base salary, target annual incentive opportunity, and annualized health care subsidy upon specified terminations. Other designated executives and employees are eligible for a severance payment equal to one times the sum of these components. All participants will also receive accrued obligations and a prorated annual incentive award based on actual performance for the portion of the year worked. Eligibility for these benefits requires the execution of a release of claims.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Chemours Company published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-260863), on October 31, 2025, and is solely responsible for the information contained therein.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.